AI
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The proposed system uses brain signals and neural patterns from children.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
The device predicts cardiac arrests using four primary vital signs.
ConcertAI is expanding its collaboration with Janssen to improve study design and increase diversity in clinical trials.
Connect America signed a definitive agreement to acquire 100Plus for an undisclosed sum.
Venture capital and private equity firm Insight Partners led the round with participation from existing investors including Equity Group Investments.
The survey results were based on responses from nearly 400 chief financial officers and revenue cycle leaders at health systems and hospitals across the United States.
Also, Ujala Cygnus opens an ICU telemedicine facility in New Delhi.
Net Health announced two AI-powered tools that could reduce the risk of amputations and predict wound healing time.